| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
5 companies
Leslie W. Kreis last filed a Form 4 in June 2025, as Director, 10% Owner at INAB. The filings on record cover 5 companies. From June 2020 to June 2025, the filings on record show 11 open-market purchases and 11 sales. Leslie W. Kreis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Leslie W. Kreis a below-average insider score of 45/100, based on 28 past trades. Over a 12-month horizon, 32.1% of those trades were profitable, with an average 12-month return of -16.7%.
At the last filing, the largest reported position was 570,724 shares of INAB. Net of sales, the INAB filings show accumulation of 1,974,899 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 | AZTR Azitra, Inc. | 10% Owner | Sell | 669,317 | $0.00 | - | - | -63.7% | -97.1% | |
| Jun 21, 2023 | AZTR Azitra, Inc. | 10% Owner | Buy | 2,297,490 | $1.31 | $3,000,000.00 | -114.0% | -63.7% | -97.1% | |
| Dec 12, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 75,001 | $2.48 | $185,912.48 | +15.1% | -50.2% | -33.8% | |
| Nov 28, 2022 | CGTX Cognition Therapeutics Inc | Director, 10% Owner | Buy | 16,064 | $2.65 | $42,564.78 | +5.5% | -36.9% | -59.6% | |
| Nov 16, 2022 | CGTX Cognition Therapeutics Inc | Director | Buy | 71,000 | $1.40 | $99,400.00 | +30.0% | +32.8% | -27.0% | |
| Nov 15, 2022 | CGTX Cognition Therapeutics Inc | Director | Buy | 1,500,000 | $1.20 | $1,800,000.00 | -125.0% | +24.8% | -27.6% | |
| Nov 8, 2022 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 350,000 | $4.40 | $1,540,000.00 | -68.1% | +36.7% | -36.2% | |
| Sep 28, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 25,000 | $2.02 | $50,535.00 | +4.7% | -13.3% | -47.1% | |
| Sep 2, 2022 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 6,445 | $5.20 | $33,514.00 | -19.8% | -3.8% | -10.4% | |
| Aug 29, 2022 | INAB In8bio, Inc. | Director, 10% Owner | Buy | 51,214 | $2.02 | $103,340.14 | +10.1% | -24.2% | -44.0% |